The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Paulson Richard A. since 2022.
This trader's CIK number is 1804460.
At the time of last reporting, Paulson Richard A. was the President and CEO of Karyopharm Therapeutics Inc.. (stock ticker symbol KPTI).
Also see all insider trading activities at Karyopharm Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KPTI | 0 | $0 | 20,329 | $81,990 | 0 | $0 |
| 2024 | KPTI | 0 | $0 | 136,874 | $154,925 | 0 | $0 |
| 2023 | KPTI | 0 | $0 | 80,870 | $212,790 | 0 | $0 |
| 2022 | KPTI | 0 | $0 | 13,943 | $70,052 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-06 | KPTI | Sale | 236 | 7.12 | 1,680 |
| 2025-04-04 | KPTI | Sale | 245 | 3.74 | 916 |
| 2025-03-04 | KPTI | Sale | 11,694 | 6.29 | 73,555 |
| 2025-02-04 | KPTI | Sale | 4,099 | .65 | 2,664 |
| 2025-01-06 | KPTI | Sale | 4,055 | .78 | 3,175 |
| 2024-11-05 | KPTI | Sale | 3,675 | .91 | 3,347 |
| 2024-10-04 | KPTI | Sale | 3,607 | .88 | 3,170 |
| 2024-09-04 | KPTI | Sale | 3,667 | .72 | 2,647 |
| 2024-08-06 | KPTI | Sale | 3,608 | .93 | 3,355 |
| 2024-07-05 | KPTI | Sale | 3,616 | .85 | 3,077 |
| 2024-06-04 | KPTI | Sale | 3,592 | .99 | 3,556 |
| 2024-05-06 | KPTI | Sale | 3,576 | 1.13 | 4,040 |
| 2024-04-04 | KPTI | Sale | 3,563 | 1.29 | 4,596 |
| 2024-03-01 | KPTI | Sale | 19,374 | 1.20 | 23,248 |
| 2024-02-29 | KPTI | Sale | 80,470 | 1.17 | 94,149 |
| 2024-02-06 | KPTI | Sale | 4,012 | 1.59 | 6,367 |
| 2024-01-04 | KPTI | Sale | 4,114 | .82 | 3,373 |
| 2023-12-04 | KPTI | Sale | 3,622 | .79 | 2,861 |
| 2023-11-06 | KPTI | Sale | 3,606 | .92 | 3,317 |
| 2023-10-04 | KPTI | Sale | 3,589 | 1.27 | 4,558 |
| 2023-09-05 | KPTI | Sale | 3,622 | 1.32 | 4,799 |
| 2023-08-07 | KPTI | Sale | 3,722 | 1.72 | 6,401 |
| 2023-07-05 | KPTI | Sale | 3,538 | 1.72 | 6,085 |
| 2023-06-05 | KPTI | Sale | 3,536 | 2.24 | 7,920 |
| 2023-05-04 | KPTI | Sale | 3,805 | 3.35 | 12,754 |
| 2023-04-04 | KPTI | Sale | 3,497 | 3.97 | 13,883 |
| 2023-03-06 | KPTI | Sale | 3,506 | 3.16 | 11,078 |
| 2023-03-01 | KPTI | Sale | 33,033 | 3.03 | 100,056 |
| 2023-02-06 | KPTI | Sale | 3,950 | 3.40 | 13,430 |
| 2023-01-04 | KPTI | Sale | 3,922 | 3.27 | 12,824 |
| 2023-01-04 | KPTI | Sale | 3,922 | 3.27 | 12,824 |
| 2022-11-04 | KPTI | Sale | 3,493 | 4.54 | 15,858 |
| 2022-09-08 | KPTI | Sale | 3,479 | 5.24 | 18,240 |
| 2022-08-04 | KPTI | Sale | 2,314 | 4.48 | 10,366 |
| 2022-07-08 | KPTI | Sale | 2,115 | 5.18 | 10,947 |
| 2022-06-07 | KPTI | Sale | 2,542 | 5.76 | 14,641 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paulson Richard A. (President and CEO of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.